Keywords: Vectura, Citi upbeat, Merck KGaA, A&Pa upgrade, Share price target, Credit rating

Citi upbeat on Vectura; S&P's upgrades Merck KGaA

Article | 02 December 2012

Print This

In a report issued last week on UK drug delivery specialties Vectura (LSE: VEC), analysts at Citi Research Investment say ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in